Phase 1 Refractory Non-Hodgkin Lymphoma trials recruiting now

All Refractory Non-Hodgkin Lymphoma trials, every phase

Phase 1 Refractory Non-Hodgkin Lymphoma trials

• Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
  NCT05077527 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
  NCT06343311 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
  NCT04851119 · Phase: Phase 1, Phase 2 · Ages: 12 Months to 30 Years · Sex: All (male and female) · 42 locations

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.